These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28436760)

  • 1. Diabetes Management by Probiotics: Current Knowledge and Future Pespective.
    Homayouni-Rad A; Soroush AR; Khalili L; Norouzi-Panahi L; Kasaie Z; Ejtahed HS
    Int J Vitam Nutr Res; 2016 Jun; 86(3-4):215-227. PubMed ID: 28436760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Future of Diabetes Management by Healthy Probiotic Microorganisms.
    Rad AH; Abbasalizadeh S; Vazifekhah S; Abbasalizadeh F; Hassanalilou T; Bastani P; Ejtahed HS; Soroush AR; Javadi M; Mortazavian AM; Khalili L
    Curr Diabetes Rev; 2017; 13(6):582-589. PubMed ID: 27758705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives.
    Panwar H; Rashmi HM; Batish VK; Grover S
    Diabetes Metab Res Rev; 2013 Feb; 29(2):103-12. PubMed ID: 23225499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling probiotic and gut microbiota functionality through proteomics.
    Ruiz L; Hidalgo C; Blanco-Míguez A; Lourenço A; Sánchez B; Margolles A
    J Proteomics; 2016 Sep; 147():28-39. PubMed ID: 27003613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report.
    Isolauri E; Salminen S;
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S91-6. PubMed ID: 18542035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota, probiotics and diabetes.
    Gomes AC; Bueno AA; de Souza RG; Mota JF
    Nutr J; 2014 Jun; 13():60. PubMed ID: 24939063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and probiotics: Focus on diabetes mellitus.
    Bordalo Tonucci L; Dos Santos KM; De Luces Fortes Ferreira CL; Ribeiro SM; De Oliveira LL; Martino HS
    Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2296-2309. PubMed ID: 26499995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, gut microbiota, and their influence on host health and disease.
    Sánchez B; Delgado S; Blanco-Míguez A; Lourenço A; Gueimonde M; Margolles A
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27500859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli.
    van Baarlen P; Wells JM; Kleerebezem M
    Trends Immunol; 2013 May; 34(5):208-15. PubMed ID: 23485516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal colonisation, microbiota and future probiotics?
    Salminen S; Benno Y; de Vos W
    Asia Pac J Clin Nutr; 2006; 15(4):558-62. PubMed ID: 17077076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.
    Hampe CS; Roth CL
    Endocrine; 2017 Nov; 58(2):207-227. PubMed ID: 29052181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.